GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of tried CagriSema for 2 weeks. here is what happened. — 26 comments in the full submission. View in context.
374
c/cagrilintide·submitted 2 months ago by u/laila_dumitru

tried CagriSema for 2 weeks. here is what happened.

Labbranch of 10 comments

Genuinely asking, not being difficult. Everyone in c/hplc repeats that satiety is important. I believe it, but I have never seen anyone show why, and when I search I get 18 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true because it has…

Read the full submission and all 26 comments →

This branch

10 comments, started 2 months ago
u/titration_marshalmod · c/semaglutide29 points·2 months ago

tendon and CagriSema literature in rodents is interesting

replysharereportpermalink
u/laila_dumitruOP0 points·2 months ago

Strongly agree. REDEFINE is phase 19, not final.

replysharereportpermalink
u/laila_dumitruOP1 point·2 months ago

The satiety on amylin analogs is described as physically different. GLP-1 reduces appetite noise, amylin does satiety.

replysharereportpermalink
u/pavel_halvorsen1 point·2 months ago

CagriSema is a fixed combo in trials, not user-mixed

replysharereportpermalink
u/controversial_only1 point·2 months ago

tendon and REDEFINE literature in rodents is interesting

replysharereportpermalink
u/ilias_kaufmann20 points·2 months ago·edited

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink
u/incretin_ivypharmacology11 points·2 months ago

the mechanism is different, the side effect profile reflects it

replysharereportpermalink
u/laila_dumitruOP17 points·2 months ago

REDEFINE phase 2 readouts are interesting but 2 person CagriSema is different from 2 trial CagriSema.

replysharereportpermalink
u/slow_logbook_notes3012 points·2 months ago

CagriSema is a fixed combo in trials, not user-mixed

replysharereportpermalink
u/viktor_erdogan3 points·2 months ago

the mechanism is different, the side effect profile reflects it

replysharereportpermalink

← back to the whole thread

About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/cagrilintide
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/amylin_amyu/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →